Enanta Pharmaceuticals Inc Q2 FY2023 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2023 Q2 Call date: 2023-05-08 Concluded

Quarter scorecard

Revenue

$17.80M

-4.9% YoY

Diluted EPS

$-1.79

Net income

-$37.66M

Royalty $17.80M

-4.9%

License $0